Christopher B. Primiano
2019
In 2019, Christopher B. Primiano earned a total compensation of $1.6M as Executive Vice President, Chief Business Officer, General Counsel and Secretary at Karyopharm Therapeutics, a 7% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $175,979 |
|---|---|
| Option Awards | $660,881 |
| Salary | $418,200 |
| Stock Awards | $356,427 |
| Other | $11,860 |
| Total | $1,623,347 |
Primiano received $660.9K in option awards, accounting for 41% of the total pay in 2019.
Primiano also received $176K in non-equity incentive plan, $418.2K in salary, $356.4K in stock awards and $11.9K in other compensation.
Rankings
In 2019, Christopher B. Primiano's compensation ranked 6,932nd out of 13,971 executives tracked by ExecPay. In other words, Primiano earned more than 50.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,932 out of 13,971 | 50th |
Division Manufacturing | 2,649 out of 5,701 | 54th |
Major group Chemicals And Allied Products | 965 out of 2,200 | 56th |
Industry group Drugs | 815 out of 1,886 | 57th |
Industry Pharmaceutical Preparations | 597 out of 1,398 | 57th |
Source: SEC filing on April 9, 2020.
Primiano's colleagues
We found three more compensation records of executives who worked with Christopher B. Primiano at Karyopharm Therapeutics in 2019.